Shareholders kick as GlaxoSmithKline  announces exit from Nigeria  

GSK UK Group has notified GlaxoSmithKline Consumer Nigeria PLC that it plans to end commercialization of its prescription medicines and vaccines in Nigeria.

The Company made this announcement via an official statement signed by Company Secretary, Frederick Ichekwai which was sent to the Nigeria Exchange Limited (NGX), Nairametrics reported.

According to its unaudited HY 2023 financial statement, the company noted that it would appoint a local third-party distributor in Nigeria for the supply of its consumer healthcare products.

More subsequently…


News continues after this Advertisement


Please enter your comment!
Please enter your name here